Our AUCs for serum CXCL9, CXCL10 and CXCL11 in the differential diagnosis of CVD–ILD from IPAF and IPF suggest that these serum chemokines may be diagnostic biomarkers of ILD with autoimmunity. Here, CXCL9 is linked to interstitial lung disease.